856258-01-0

Upstream product

• 108-24-7 acetic anhydride 
• 89449-82-1 4-nitro-1-phenyl-3-pentanol 
• 104-53-0 3-phenyl-propionaldehyde 

Downstream Products

• 112402-56-9 2-Nitro-5-phenylpent-2-ene 
• 112402-46-7 (E)-2-Methyl-2-nitro-5-phenyl-pent-3-en-1-ol 
• 145101-09-3 ethyl 4-methyl-3-phenethyl-2-pyrrolecarboxylate 
• 188554-85-0 3-Benzyloxy-2-nitro-5-phenylpentane 
• 863642-95-9 Acetic acid (E)-2-methyl-2-nitro-5-phenyl-pent-3-enyl ester 

Relevant academic research and scientific papers

On the [2,3] sigmatropic rearrangement of allylic nitro compounds

(Chemical Equation Presented) Allylic nitro compounds undergo relatively clean [2,3] sigmatropic rearrangement upon heating in refluxing 1,2-dichlorobenzene in the presence of DABCO to give the corresponding allylic alcohols via the intermediate allylic n

Pyrrole and pyrazole DAAO inhibitors

Methods for increasing D-Serine concentration and reducing concentration of the toxic products of D-Serine oxidation, for enhancing learning, memory and/or cognition, or for treating schizophrenia, Alzheimer's disease, ataxia or neuropathic pain, or preventing loss in neuronal function characteristic of neurodegenerative diseases involve administering to a subject in need of treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt or solvate thereof: wherein R1 and R2 are independently selected from hydrogen, halo, nitro, alkyl, acyl, alkylaryl, and XYR5; or R1 and R2, taken together, form a 5, 6, 7 or 8-membered substituted or unsubstituted carbocyclic or heterocyclic group; X and Y are independently selected from O, S, NH, and (CR6R7)n; R3 is hydrogen, alkyl or M+; M is aluminum, calcium, lithium, magnesium, potassium, sodium, zinc ion or a mixture thereof; Z is N or CR4; R4 is from selected from hydrogen, halo, nitro, alkyl, alkylaryl, and XYR5; R5 is selected from aryl, substituted aryl, heteroaryl and substituted heteroaryl; R6 and R7 are independently selected from hydrogen and alkyl; n is an integer from 1 to 6; at least one of R1, R2 and R4 is other than hydrogen; and at least one of X and Y is (CR6R7)n. D-serine or cycloserine may be coadministered along with the compound of formula I.

A mild oxidative transformation of nitro compounds into ketones by tetrapropylammonium perruthenate

Oxidation of secondary nitro compounds with a catalytic amount of tetrapropylammonium perruthenate in the presence of N-methylmorpholine N-oxide, silver(I) acetate, potassium carbonate and 4 A molecular sieves provides the corresponding ketones in moderat